Valhi, Inc. (VHI)
After hours:
| Previous Close | 45.34 |
| Open | 44.73 |
| Bid | 29.24 x 800 |
| Ask | 72.00 x 1100 |
| Day's Range | 43.43 - 46.83 |
| 52 Week Range | 21.11 - 54.06 |
| Volume | |
| Avg. Volume | 43,953 |
| Market Cap | 1.283B |
| Beta (5Y Monthly) | 1.57 |
| PE Ratio (TTM) | 8.20 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.32 (0.71%) |
| Ex-Dividend Date | Jun 03, 2022 |
| 1y Target Est | N/A |
- GlobeNewswire
VALHI ANNOUNCES QUARTERLY CASH DIVIDEND AND RESULTS OF ANNUAL STOCKHOLDER MEETING
Dallas, Texas, May 26, 2022 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) announced today that its board of directors has declared a regular quarterly dividend of eight cents ($0.08) per share on its common stock, payable on June 23, 2022 to stockholders of record at the close of business on June 6, 2022. Valhi also announced that at its annual stockholder meeting held on May 26, 2022, its stockholders: elected each of Thomas E. Barry, Loretta J. Feehan, Robert D. Graham, Terri L. Herrington, W. H
- GlobeNewswire
VALHI REPORTS FIRST QUARTER 2022 RESULTS
Dallas, Texas, May 05, 2022 (GLOBE NEWSWIRE) -- Valhi, Inc. (NYSE: VHI) reported net income attributable to Valhi stockholders of $45.4 million, or $1.59 per share, in the first quarter of 2022 compared to $14.8 million, or $.52 per share, in the first quarter of 2021. Net income attributable to Valhi stockholders increased in the first quarter of 2022 as compared to the first quarter of 2021 primarily due to higher operating results from our Chemicals Segment. The Chemicals Segment’s net sales
- GlobeNewswire
VitalHub Announces a Multi-Year Regional Licensing Contract with NHS England and NHS Improvement Midlands
TORONTO, April 11, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) is pleased to announce a multi-year regional licensing agreement of subsidiary Transforming Systems (“TS”) SHREWD suite of solutions with NHS England and NHS Improvement Midlands (“NHSEI” or the “Customer”). This transaction marks a new customer sale for the Company, with TS having engaged with NHSEI since July 2021. The Customer, NHSEI, provides care for a population of 10.5 million people, acros
